Cargando…
Novel agents in the treatment of multiple myeloma: a review about the future
Multiple myeloma (MM) is a disease that affects plasma cells and can lead to devastating clinical features such as anemia, lytic bone lesions, hypercalcemia, and renal disease. An enhanced understanding of MM disease mechanisms has led to new more targeted treatments. There is now a plethora of trea...
Autores principales: | Naymagon, Leonard, Abdul-Hay, Maher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929712/ https://www.ncbi.nlm.nih.gov/pubmed/27363832 http://dx.doi.org/10.1186/s13045-016-0282-1 |
Ejemplares similares
-
Primary extramedullary plasmacytoma with diffuse lymph node involvement: a case report and review of the literature
por: Naymagon, Leonard, et al.
Publicado: (2019) -
Novel Agents for the Treatment of Multiple Myeloma: Proteasome Inhibitors and Immunomodulatory Agents
por: Kurtin, Sandra E., et al.
Publicado: (2013) -
Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment
por: Morè, Sonia, et al.
Publicado: (2023) -
A Systematic Review of Cost-Effectiveness Analyses of Novel Agents in the Treatment of Multiple Myeloma
por: Seefat, Maarten R., et al.
Publicado: (2021) -
Front line treatment of elderly multiple myeloma in the era of novel agents
por: Venon, Marie-Dominique, et al.
Publicado: (2009)